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C. elegans: A Model for Exploring
the Genetics of Fat Storage
greater than 60% of human disease genes have inverte-
brate orthologs (Hodgkin et al., 1998; Jasny, 2000). As
C. elegans is an excellent model for many biological
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processes, it seemed plausible that it might also prove2 Department of Molecular Biology
to be a powerful system for analyzing the mechanisms ofUniversity of Texas Southwestern Medical Center
fat storage. There are several clues that these processes6000 Harry Hines Boulevard
might be related in worms and mammals, including dataDallas, Texas 75390
demonstrating that neuropeptide, serotonergic, and in-
sulin signaling pathways regulate fat storage in both
nematodes and mammals (Kimura, 1997; Leibowitz and
Summary Alexander, 1998; Sze et al., 2000; Wang et al., 1998).
For example, serotonin 5-HT2C receptor knockout mice
To gain insights into the genetic cascades that regu- and worms lacking serotonin signaling accumulate ex-
late fat biology, we evaluated C. elegans as an appro- cess fat (Sze et al., 2000; Nonogaki et al., 1998). Insulin
priate model organism. We generated worms that lack signaling is a primary mechanism for controlling meta-
two transcription factors, SREBP and C/EBP, crucial bolic physiology not only in humans, but also in worms
for formation of mammalian fat. Worms deficient in (Kimura, 1997). In addition, worms have homologs of
either of these genes displayed a lipid-depleted phe- many mammalian lipogenic and lipolytic enzymes (C.
notype—pale, skinny, larval-arrested worms that lack elegans Sequencing Consortium, 1998). Worms also
fat stores. On the basis of this phenotype, we used a contain homologs of the transcription factors C/EBP
reverse genetic screen to identify several additional and SREBP (see below), which regulate mammalian adi-
genes that play a role in worm lipid storage. Two of pocyte differentiation (Rosen et al., 2000). C. elegans
the genes encode components of the mitochondrial therefore contains homologs of genes encompassing a
respiratory chain (MRC). When the MRC was inhibited wide range of components of the mammalian fat regula-
chemically in worms or in a mammalian adipocyte tory cascade, including hormonal regulators, differentia-
model, fat accumulation was markedly reduced. A tion factors, and biosynthetic enzymes.
third encodes lpd-3, whose homolog is also required There are some potential problems with using worms
for fat storage in a mammalian model. These data as a model for fat biology. In worms, the intestine, an
suggest that C. elegans is a genetically tractable endodermal derivative, is the major site of energy stores,
model to study the mechanisms that underlie the biol- which are contained in several types of gut granules;
ogy of fat-storing tissues. some contain protein and carbohydrate, while others
are lipid-laden, “fat granules” (Wood, 1988). In contrast,
mammalian fat is thought to be a mesodermal derivative.Introduction
Furthermore, worm intestinal cells are multifunctional
and are not dedicated adipocytes, as in mammals. How-An organism’s ability to regulate the production, stor-
ever, the important aspect of a worm model is that theage, and release of energy is crucial for health and sur-
genetic (i.e., molecular) control must be conserved be-vival. A major source of energy is stored as fat, which
tween worm fat granules and mammalian fat.is required for the life cycle of many organisms (Camp-
Here we report our analysis of C. elegans as a systembell and Dhand, 2000; Spiegelman and Flier, 2001). Un-
for studying the genetics of fat. We first characterized
fortunately, abnormalities in fat accumulation produce
C. elegans homologs of two mammalian genes, SREBP
pathological states. Lipodystrophy, too little fat, pro-
and C/EBP, that control mammalian adipogenesis (Ro-
duces severe metabolic disturbances, including hyper- sen et al., 2000). The worm SREBP homolog was ex-
triglyceridemia and early onset type II diabetes mellitus pressed in the endodermal fat-storing cells, and RNA-
(Garg, 2000). The converse disease state, obesity, in- mediated interference (RNAi) targeting either SREBP or
creases the risk of heart disease, type II diabetes, hyper- C/EBP resulted in pale, skinny larval-arrested worms.
tension, and other diseases (Must et al., 1999). The These worms lacked fat stores and had reduced expres-
alarming worldwide increase in obesity has intensified sion of lipogenic enzymes, suggesting a conserved role
the search to identify genes that control the develop- for SREBP and C/EBP from nematodes to mammals.
ment, differentiation, and function of fat-storing tissues. With a reverse genetic approach, we also identified sev-
While some key regulators of these pathways were iden- eral new genes that gave a similar, fat-depleted pheno-
tified with biochemistry and cell culture systems (re- type upon RNAi. The genes identified in our reverse
viewed in Rosen et al., 2000), an appropriate invertebrate genetic screen represent a variety of cellular processes,
genetic model system might hasten the discovery of suggesting that this approach might identify novel path-
new genes important in fat biology. ways that regulate fat storage.
Model organisms are a powerful resource for the dis- If the C. elegans model is robust, some of the genes
covery of genes critical to human health and disease: we identified in worms should also play roles in mamma-
lian fat biology. To test that notion, we chose three of
the genes found in our worm screen and characterized*Correspondence: jon.graff@utsouthwestern.edu
3These authors contributed equally to this work. them in greater detail. Two encode components of the
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mitochondrial respiratory chain (MRC); worms grown in strong GFP expression, exclusively in the intestine (Fig-
the presence of chemical inhibitors of MRC function ure 2A).
arrested at early larval stages and had reduced fat, simi-
lar to the RNAi phenotype. We extended the data to a
RNAi against Worm SREBP and C/EBP Resultsmammalian adipocyte model, 3T3-L1 tissue culture
in Larval-Arrested Worms that Lack Fatcells, and found that, just as in worms, lipid accumula-
The expression pattern of Y47D38.7 (SREBP) was con-tion in 3T3-L1 cells was blocked when the cells were
sistent with a possible role for the gene in formation orcultured in the same chemical inhibitors. The third gene,
accumulation of fat in worms. To elucidate the endoge-lpd-3, encodes a large, novel protein that, like SREBP,
nous roles of Y47D38.7 (SREBP) and C48E7.3 (C/EBP),is expressed in the worm intestine, the site of fat storage.
we performed RNAi to block their function (Fire et al.,The mammalian lpd-3 homolog is expressed dynami-
1991, 1998). RNAi against either gene produced a similarcally in murine and human fat. Notably, murine lpd-3 is
phenotype: pale, skinny worms that arrest as early larvaerequired for lipid accumulation in the 3T3-L1 mammalian
(Figure 2B). We also observed the pale phenotype in thecell system. Taken together, these data suggest that C.
starved worms that lacked fat stores (Figure 1). Bothelegans is an appropriate model organism to study fat
the SREBP and the C/EBP RNAi worms appeared palebiology; with the model, we identified genes that func-
because the dark, lipid-laden fat granules normally pres-tion in diverse processes, and all three genes that we
ent in the intestines of wild-type worms were absenthave tested to date are required for fat storage not only
(Figure 2B). Although the RNAi worms did not containin worms, but also in mammalian systems.
fat granules, other gut granules, including a population
of gut granules that are birefringent under dark-fieldResults
optics (Leung et al., 1999; Peters et al., 1999), were
present (data not shown). This suggests that at leastC. elegans Mobilize Fat upon Starvation
some intestinal function was normal.During fasting, mammals mobilize fat stores to fulfill their
To test the worms for fat accumulation, we stainedenergy requirements. To determine whether C. elegans
them with Sudan black. We found that the C/EBP oralso utilize fat upon starvation, we removed worms from
SREBP RNAi worms, like the starved worms, did nottheir food at various stages of life. By six hours of starva-
stain with Sudan black (data not shown). We also evalu-tion, both larval and adult worms were pale and lacked
ated fat storage with Nile red, a vital dye that specificallythe dark gut granules present in well-fed animals (Figure
stains fat (Greenspan et al., 1985). This dye has the1A). Of note, fruitfly larvae lacking fat stores also appear
distinct advantage that it can fluorescently stain fat inpale and clear, so the starved worms might also have
living worms, providing a powerful tool for geneticdecreased fat. To evaluate this possibility, we fixed and
screening. Consistent with the pale phenotype and lackstained starved and well-fed worms with Sudan black,
of Sudan black staining, the RNAi worms, in contrast toa fat-specific dye (Ogg et al., 1997). While well-fed
wild-type worms, did not fluoresce when treated withworms had prominent Sudan black staining, starved
Nile red, indicating an absence of fat (Figure 2B). Thatworms displayed reduced Sudan black staining (Figure
is, in the absence of the homologs of either SREBP1B). This suggests that worms, like mammals, mobilize
or C/EBP, worms display a “lipid-depleted” phenotype:fat stores upon physiologic demand.
pale, skinny worms that lack fat. As a reflection of that,
we chose lpd-1 (lipid depleted-1) as the genetic nameWorm SREBP Is Expressed in the Intestine
for Y47D38.7 (SREBP) and lpd-2 as the genetic nameTo explore the possibility that the mechanisms that reg-
ulate fat biology are conserved, we examined the C. for C48E7.3 (C/EBP).
elegans genome to determine whether it contained ho-
mologs of genes known to be essential for mammalian
SREBP Deletion Mutants Do Not Contain Fatadipocyte differentiation. Tissue culture and biochemi-
To eliminate the possibility that the lpd phenotype mightcal studies had identified three transcription factors—
have been secondary to nonspecific RNAi effects, wePPAR, C/EBP, and SREBP-1 (ADD1)—as necessary
isolated an lpd-1 mutant, lpd-1(gf1) by screening a dele-and sufficient for mammalian adipogenesis (Rosen et
tion library (Jansen et al., 1997). The mutant containedal., 2000). If C. elegans is an appropriate model organ-
a 4 kb deletion that eliminated most of the coding region,ism, these or related genes should be required for worm
including the DNA binding domain, so the mutant shouldfat formation. Through database analysis, we identi-
behave like a null. The phenotype of the lpd-1 deletionfied SREBP-1 (Y47D38.7; 35% similarity) and C/EBP
mutant was indistinguishable from that generated with(C48E7.3; 25% similarity) homologs. PPAR, a nuclear
RNAi: larval-arrested, pale, skinny worms that did nothormone receptor (NHR), had many similar genes in
contain fat (data not shown); therefore, the lpd-1 RNAithe worm database. While mammals have less than 50
worms accurately phenocopied a genetic loss-of-func-NHRs, the worm genome contains 200 NHRs, making
tion mutant.the identification of a potential PPAR homolog difficult
Next, we examined the lpd-1(gf1) deletion mutants by(Mangelsdorf and Evans, 1995; Sluder et al., 1999). If
electron microscopy (Figure 3A). The overall ultrastruc-SREBP or C/EBP are involved cell autonomously in C.
ture appeared normal, and the worms contained theelegans fat accumulation, then they should be ex-
appropriate complement of muscle and hypodermalpressed in the intestine, the primary site of fat storage
cells. The intestinal lumen of the lpd-1(gf1) deletion mu-in the worm. To determine Y47D38.7 (SREBP) expres-
tants was intact, and the intestinal cells contained well-sion, we constructed an SREBP::GFP fusion and gener-
ated transgenic SREBP::GFP worms, which showed organized microvilli. However, the intestinal cells of the
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Figure 1. C. elegans Mobilize Fat Stores
upon Starvation
(A) Larval and adult worms were grown on
plates with food (well-fed) or on plates with-
out food for 8 hr (starved) and then micro-
scopically examined and photographed. Solid
arrows indicate the dark gut granules present
in the well-fed worms. Double arrows indicate
the absence of these granules.
(B) Well-fed and starved adult worms were
fixed and stained with Sudan black. The solid
arrow indicates fat labeled with Sudan black
(Ogg et al., 1997). The double arrow indicates
the absence of Sudan black staining in the
starved worms.
mutant worms appeared to lack the dark storage gran- the latex beads, indicating that the intestine was func-
tional and unobstructed (Figure 3B). These data are con-ules that are present in wild-type worms (Figure 3A).
Taken together, these data suggest that the intestinal sistent with the idea that the lpd phenotype was not due
to defective feeding, intestinal transit, or defecation.cells of the lpd-1(gf1) mutants have relatively normal
morphology but have a specific defect in fat storage,
leading to the lipid-depleted phenotype. Worm SREBP and C/EBP Regulate Lipogenic
Gene Expression
To attempt to explore the mechanisms that underlie theSREBP and C/EBP RNAi Worms Eat
and Defecate at Wild-Type Rates lpd phenotype observed when either C/EBP or SREBP
function was reduced, we examined the expressionIt was possible that the lipid-depleted (lpd) phenotype
was secondary to some mechanical problem in the ali- levels of candidate downstream genes. In mammals,
C/EBP and SREBP regulate the expression of a numbermentary canal; for example, the RNAi worms may be
unable to ingest or pass food as effectively as wild-type of lipogenic enzymes, including acetyl coenzyme A car-
boxylase (ACC), ATP-citrate lyase (ACL), fatty acidworms. To analyze this possibility, we examined the
pharyngeal pumping (“eating”) and defecation rates of synthase (FAS), glycerol 3-phosphate acyltransferase
(G3PA), and malic enzyme (Christy et al., 1989; Ericssonthe RNAi worms. Wild-type, lpd-1, and lpd-2 RNAi
worms had similar average pumping and average defe- et al., 1997; Kim and Spiegelman, 1996; Rosen et al.,
2000; Shimano et al., 1999). A search of the C. eleganscation rates (Figure 3B) (Wood, 1988). In contrast, eat-
2(ad465) worms pumped at a much slower rate and had genome identified candidate homologs of each. To de-
termine whether lpd-1 and lpd-2 regulate the expressionan extended defecation cycle compared with wild-type
worms (Figure 3B), as described (Raizen et al., 1995; of these lipogenic enzymes in the worm, we isolated
RNA from wild-type worms and lpd-1 and lpd-2 RNAiThomas, 1990). To test intestinal patency, we deter-
mined whether the RNAi worms could ingest and excrete worms. We first determined whether the RNAi had in-
deed decreased the expression of the targeted gene.0.8 m latex beads. Like wild-type worms, lpd-1 and
lpd-2 RNAi worms contained beads throughout the For both lpd-1 and lpd-2, the RNAi reduced the expres-
sion of the respective gene, demonstrating the efficacylength of the intestine, and both were able to defecate
Developmental Cell
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Figure 2. SREBP and C/EBP Homologs Are
Required for C. elegans Fat Storage
(A) Worm SREBP (Y47D38.7) is expressed in
the intestine. Transgenic worms expressing
an SREBP::GFP translational fusion were ex-
amined by bright-field and GFP fluorescence
microscopy.
(B) RNAi against either Y47D38.7 (SREBP) or
C48E7.3 (C/EBP) results in lipid-depleted
worms. dsRNA was injected into the gonads
of young adult hermaphrodites, and the prog-
eny were examined. The RNAi worms arrested
as larvae, and DIC microscopy showed that
they were pale and skinny compared with
wild-type worms (worms are at the same de-
velopmental stage). In wild-type worms, in-
testinal fat granules fluoresced brightly after
soaking in Nile red, a lipid-specific dye
(Greenspan et al., 1985). Worms treated with
lpd-1 (SREBP) or lpd-2 (C/EBP) dsRNA dis-
played no Nile red fluorescence.
of the RNAi (Figure 3C). lpd-2 RNAi also altered the followed by Nile red staining, of 80 genes that were
reported in two large-scale RNAi screens as having lar-expression levels of lpd-1, but the converse was not
true (Figure 3C), supporting the notion that, in worms, val phenotypes (Fraser et al., 2000; Maeda et al., 2001).
We found that 8 of the 80 genes we tested resulted inSREBP functions downstream of C/EBP. This epistatic
relationship was also recently proposed for mammals the lpd phenotype upon RNAi. These genes represented
a diverse array of cellular processes, and none of the(Rosen et al., 2002). Next, we analyzed the expression
of the lipogenic enzymes (ACC, ACL, FAS, G3PA, and genes were fatty acid biosynthetic enzymes (Table 1).
This suggests that the pathways and mechanisms thatmalic enzyme) and found that their expression levels
were decreased to varying extents when either lpd-1 or regulate formation and storage of fat are broad and
varied and extends the current view of the process.lpd-2 function was reduced (Figure 3C). As a specificity
control, we also examined the expression of an intes- Notably, seven of the eight genes we identified have
mammalian homologs. We chose to extend the analysistine-specific NaH transporter, B0495.4 (P. Bauer et al.,
WormBase submission), as well as an intestine-specific of three, lpd-3, lpd-4, and lpd-5, of those seven genes.
actin, act-5 (Jim Waddle, personal communication);
both remained unchanged in the RNAi worms (Figure MRC Function Is Required for Fat Accumulation
in Worms and in a Mammalian Cell3C). With these results taken together, the molecular
analysis suggested that SREBP and C/EBP regulate li- Culture Model
ZK973.10 (lpd-5) and F26E4.9 (lpd-4) encode compo-pogenic genes not only in mammals, but also in C. ele-
gans. nents of the mitochondrial respiratory chain (MRC),
which couples electron transport to ATP production
(Lehninger, 1982). ZK973.10 (lpd-5) encodes the MRCRNAi Pilot Screen Identifies Additional lpd Genes
Next, we attempted to identify other genes that regulate complex I NADH-ubiquinone oxidoreductase 18 kDa
subunit. F26E4.9 (lpd-4) encodes cytochrome c oxidasefat storage, by scoring for the lpd phenotype. We were
aided in this effort by large-scale RNAi screens in which Vb (COX Vb), a subunit of complex IV of the MRC. To
further examine the role of the MRC in worm fat storage,various broad categories of mutant phenotypes, includ-
ing larval arrest/lethal, were reported (Fraser et al., 2000; we cultured L4 stage larvae on control plates or plates
containing either rotenone, a specific complex I inhibi-Maeda et al., 2001). As both the lpd-1- and lpd-2-defi-
cient worms arrested as larvae, we performed RNAi, tor, or NaN3, a specific complex IV inhibitor. The F1
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Figure 3. Analysis of Lipid-Depleted Worms
(A) Electron microscopy on ultrathin trans-
verse sections of lpd-1 (SREBP) deletion mu-
tants demonstrated that the worm intestinal
cells were relatively normal, except that they
lacked dark gut granules.
(B) lpd-1 and lpd-2 RNAi worms eat and defe-
cate at rates similar to wild-type worms. The
number of pumps/minute and seconds/defe-
cation cycle was confirmed twice for each
worm (n  15). To test for intestinal patency,
worms were fed bacteria mixed with blue la-
tex beads (Sigma) and then examined at
400.
(C) The expression of several lipogenic en-
zymes was downregulated in lpd-1 and lpd-2
RNAi worms. Feeding RNAi was performed
(Fraser et al., 2000) with an empty vector,
HT115 (con), or with the indicated DNA insert,
lpd-1 or lpd-2, and the worms were harvested
for RT-PCR. Totals of 0.5 g and 1 g of
cDNA template were used to ensure that the
PCR was semiquantitative.
Table 1. Genes Required for Fat Storage Identified by Pilot Screen
Worm Gene WormBase Gene Name/Function Mammalian Homolog
lpd-3 Y47G6A.23 novel 
lpd-4 F26E4.9 cytochrome c oxidase subunit Vb 
lpd-5 ZK973.10 NADH-upiquinone oxidoreductase 18 kDa subunit 
lpd-6 K09H9.6 Peter Pan homolog 
lpd-7 R13A5.12 Pescadillo homolog 
lpd-8 R10H10.1 nitrogen-fixing domain/RNA binding domain 
mac-1 Y48C3A.6 AAA-ATPase 
lpd-9 T21C9.5 novel 
Developmental Cell
136
Figure 4. Inhibiting MRC Function Blocks
Lipid Accumulation in Worms and 3T3-L1
Cells
(A) Worms cultured on the indicated chemical
MRC inhibitor were stained with Nile red and
examined by DIC and fluorescence mi-
croscopy.
(B) Murine 3T3-L1 cells were induced to be-
come adipocytes as described (MacDougald
and Lane, 1995). At day 2 postinduction, 5
M rotenone, a complex I inhibitor, or 5 mM
NaN3, a complex IV inhibitor, was added to
the media. Fresh media and inhibitors were
added every other day. At day 8 postinduc-
tion, cells were fixed and then stained with
oil red O as described (Green and Kehinde,
1975). Induced cells (IND) accumulate lipid
(red). Uninduced (UN) cells and inhibitor-
treated, induced cells accumulate much less
lipid.
(C) 3T3-L1 cells, treated as in (B), were har-
vested with Trizol, treated with DNase I, and
analyzed, on day 3 of induction, for expres-
sion of the indicated adipogenic markers by
semiquantitative RT-PCR. The RT samples
had no reverse transcriptase included in the
reaction.
progeny cultured on control plates were examined and fate-specific markers, including C/EBP, PPAR, SREBP,
aP2, and LPL (Cornelius et al., 1994; Green and Kehinde,found to be healthy in appearance, with dark gut gran-
ules in their intestines that stained brightly with Nile red 1975). If the functions of COX Vb and NADH-ubiquinone
oxidoreductase were conserved from worms to mam-(Figure 4A). Many of the F1 progeny of the worms on
the inhibitor plates were pale and skinny and had re- mals, then blocking their function in 3T3-L1 cells should
decrease lipid accumulation. To test that notion, weduced Nile red staining (Figure 4A). EM analysis of the
MRC-inhibited worms demonstrated that they are mor- grew 3T3-L1 cells to confluence, induced adipogenesis
with the appropriate culture media (MacDougald andphologically normal, with developed muscle, hypoder-
mal, and intestinal cells (data not shown). Taken Lane, 1995), and then added rotenone to inhibit complex
I or NaN3 to inhibit complex IV. By day 6 postinduction,together, these results indicate that reducing MRC func-
tion in C. elegans specifically alters fat storage. a large percentage of the cells cultured in induction
media without inhibitor had differentiated into adipo-Mutations in genes that function in the MRC have been
linked to abnormalities in fat accumulation in humans, cytes, as evidenced by morphological changes and the
accumulation of lipid droplets, which stained red withincluding lipodystrophy (Brinkman et al., 1999; Zaera et
al., 2001), suggesting that the lpd-4 and lpd-5 genes the lipophilic dye oil red O (Figure 4B) and fluoresced
brightly when stained with Nile red (data not shown).identified in C. elegans might also be important in mam-
malian fat storage. To investigate the potential role of However, induced cells cultured in the presence of either
MRC inhibitor contained much less lipid (Figure 4B).the MRC in mammalian fat accumulation, we turned to
a murine adipocyte model system—3T3-LI tissue culture To determine whether MRC inhibitor treatment blocked
cellular differentiation or lipid accumulation, we as-cells. Under standard culture conditions, these cells be-
have like fibroblasts, but, in the presence of a defined sessed the expression of fat cell differentiation markers.
We found that inhibitor-treated cells expressed cell fatehormonal induction mix, the cells differentiate into adi-
pocytes that accumulate lipid and express appropriate markers, as did induced controls (Figure 4C and data
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Figure 5. lpd-3 Is Expressed in the Worm In-
testine and in Mammalian Fat
(A) lpd-3 is expressed in the intestine. Trans-
genic worms expressing an lpd-3::GFP trans-
lational fusion were examined by bright-field
and GFP fluorescence microscopy.
(B) The human homolog of lpd-3 is expressed
in fat, brain, and testis. PCR with human lpd-3
primers was performed with a panel of cDNA
from 16 different human tissues as template.
S9 ribosomal PCR is a loading control.
(C) Mouse lpd-3 is expressed at higher levels
in induced 3T3-L1 (IND) than in uninduced
(UN) 3T3-L1 cells. 3T3-L1 cells were grown
with (IND) or without (UN) induction media
and then harvested for RT-PCR. G3PDH is
a loading control. PPAR is upregulated in
induced cells, while Pref-1 is downregulated.
(D) Mouse lpd-3 is expressed at higher levels
in the mouse embryonic day 14.5 fat enlagen
than in adult fat. PPAR and adipsin, a marker
of terminal differentiation, are expressed at
higher levels in adult fat. The RT samples
had no reverse transcriptase included in the
reaction.
not shown). In some experiments, the level of PPAR, fragment of mouse lpd-3 (mlpd-3) based upon the hu-
man sequence and designed mouse-specific primers.C/EBP, and SREBP-1 expression was less in inhibitor-
treated cells than in induced, untreated cells, which may RT-PCR with these primers demonstrated that mlpd-3
is dynamically regulated in two murine systems. First,be secondary to feedback regulation (Rosen et al., 2000).
Taken together, these data support the notion that MRC we analyzed the expression of mlpd-3 in the 3T3-L1
model and, as controls, also assessed levels of PPARfunction, in worms and mammals, is important in lipid
accumulation. and pref-1, which mark distinct stages of 3T3-L1 adipo-
cyte differentiation (Sul et al., 1998; Tontonoz et al.,
1994). We found that PPAR is expressed at very low
lpd-3 Is Expressed in the Worm Intestine levels in uninduced cells and is markedly upregulated
and in Mammalian Fat during induction, while pref-1 had the opposite pattern
Y47G6A.23 (lpd-3) is predicted to encode a protein with of expression, consistent with the literature (Figure 5C).
an open reading frame of 1590 amino acids that contains mlpd-3 had a low level of expression in the uninduced
a presumptive signal sequence and a putative coiled- cells, and this level increased during adipogenesis in a
coil domain. On the basis of the lipid-depleted phe- manner similar to PPAR (Figure 5C).
notype of Y47G6A.23 dsRNA animals, we named this To directly examine endogenous gene expression, we
gene lpd-3. lpd-3::GFP transgenic worms, like lpd-1 harvested RNA from adult white fat pads and from the
(SREBP)::GFP worms, displayed prominent GFP expres- presumptive fat pad at embryonic day 14.5 and analyzed
sion in the intestine, the site of fat storage, consistent the expression of mlpd-3, PPAR, and adipsin. We found
with a cell-autonomous effect, producing the lipid- that adipsin was not expressed at E14.5 but was strongly
depleted phenotype (Figure 5A). Database analysis de- expressed in adult fat, as expected of a gene that marks
tected related ESTs in both flies (32% similarity) and terminally differentiated fat (Figure 5D) (Cook et al.,
humans (32% similarity). We then examined the distribu- 1987). PPAR also had highest levels of expression in
tion of human lpd-3 (hlpd-3) in 16 human tissues and the adult fat, but, unlike adipsin, PPAR also had a
found that the hlpd-3 transcript is most highly expressed modicum of expression in the embryonic fat enlagen at
in brain, testis, and adipose tissue (Figure 5B). To extend E14.5 (Figure 5D). Notably, mlpd-3 was highly expressed
in the embryonic fat, with lower levels in the mature,the lpd-3 data to mouse model systems, we cloned a
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fully differentiated fat (Figure 5D). Therefore, lpd-3 is of PPAR, indicating an ineffective knockdown. All three
lines that lacked lipid stores had reduced PPAR ex-expressed in fat storing tissues from worms to humans,
and its expression is highest in developing fat, poten- pression (Figure 6B). Strikingly similar results were ob-
tained with the mlpd-3 shRNA cell lines (Figures 6C andtially presaging PPAR expression.
6D). That is, when mlpd-3 expression was reduced, lipid
accumulation was abrogated, but those clones that re-mlpd-3 Is Required for Mammalian
tained mlpd-3 expression stored fat normally (FiguresFat Accumulation
6C and 6D). We have undertaken similar studies withThe worm studies coupled with the mammalian expres-
many of our shRNA cell lines, and one with a low levelsion data support the notion that lpd-3 might function
of mlpd-3 did accumulate lipid (data not shown). Weduring mammalian fat formation. To investigate that po-
found similar inconsistent results with a PPAR shRNAtential role, we exploited the 3T3-L1 adipocyte culture
stable clone. Next, we analyzed the induced cell linessystem for tests of lpd-3 necessity. As lpd-3 does not
for expression of markers of adipocyte differentiation.contain well-established structural domains, it was not
As expected, the expression of the markers was mark-possible to rationally design dominant-negative forms
edly reduced in the PPAR shRNA lines that had lowto block lpd-3 function. However, RNAi was recently
levels of PPAR expression (Figure 6E). However, mlpd-shown to be an effective loss-of-function methodology
3 expression was not altered by reduction of PPARin some mammalian cell lines (Caplan et al., 2001; El-
(Figure 6E), which suggests that mlpd-3 expression isbashir et al., 2001), although no data has been reported
not regulated by PPAR. We also found that levels offor 3T3-L1 cells. As the process of 3T3-L1 adipogenesis
the cell fate markers were reduced in the mlpd-3 shRNAtakes many days, we needed to stably inhibit the func-
cells lacking the normal complement of mlpd-3 (Figuretion of lpd-3. Of note, a new approach to RNAi for mam-
6E). Of note, PPAR expression was reduced in themalian cells, termed short-hairpin RNAi (shRNA), relies
mlpd-3-deficient lines, suggesting that its transcrip-on the expression of a short-hairpin RNA from a DNA-
tional regulation is dependent on mlpd-3 (Figure 6E).based vector (Brummelkamp et al., 2002; Yu et al., 2002),
That is, these data are consistent with the notion thatwhich should provide the ability to generate stable
mlpd-3 functions upstream of PPAR; however, it isclones that express an shRNA to the gene of interest.
possible that a feedback network underlies these find-We obtained an shRNA vector, mU6-Pro (Yu et al., 2002),
ings (Rosen et al., 2000). Taken together, these datain which the shRNA is transcribed from the mU6 RNA
demonstrate that lpd-3 is required for fat accumulationpolymerase III promoter, and we cloned the neomycin
in a mammalian model.gene, under control of the PGK promoter, into the vector
in order to generate stable cell lines.
To take advantage of the shRNA approach, we con- Discussion
structed a vector (neo-mU6-mlpd3) containing a hairpin
structure that was designed to decrease expression of The ability to regulate fat storage is a fundamental pro-
cess that is required for the life cycle of many multicellu-mlpd-3. Then, we transfected the vector into 3T3-L1
cells and selected stable lines with G418. In a pilot study, lar organisms, and abnormalities in fat storage underlie
important human diseases (Campbell and Dhand, 2000).we found that the majority of the neo-mU6-lpd-3 shRNA
stable clones had lower levels of lpd-3 expression (data Invertebrates are powerful tools for gene discovery, yet
they have not been fully exploited in the study of fatnot shown). Next, we induced the lpd-3 shRNA 3T3-L1
cells to undergo adipogenesis and found that the clones development or function. In this report, we have encour-
aging data suggesting that C. elegans intestinal fat gran-that contained low levels of the lpd-3 transcript accumu-
lated much less fat than those cells with wild-type lpd-3 ules might provide an invertebrate model amenable to
the study of fat. Database analysis identified C. eleganslevels. On the basis of these results, we decided to
undertake a more detailed analysis that included a posi- genes that were homologous to SREBP and C/EBP,
transcription factors that are required for mammaliantive shRNA control, for which we selected PPAR, which
is required for 3T3-L1 adipogenesis. We generated the adipogenesis. Blocking the function of these genes re-
sulted in lipid-depleted worms that arrest as larvae, areappropriate plasmid, neo-mU6-PPAR, and simultane-
ously selected many new stable clones containing either pale and skinny, and lack fat. That is, the same genes
that are required for mammalian adipocyte differentia-neo-mU6-mlpd-3 or neo-mU6-PPAR. To assess the
efficacy of the RNAi effect, we evaluated the levels of tion also appear essential for fat accumulation in worms.
In addition, SREBP and C/EBP regulate the expressionexpression of the salient genes with RT-PCR. Again,
slightly more than 50% of the clones of each type dem- of the same lipogenic enzymes in worms and mammals.
These data are consistent with the notion that wormonstrated significant reduction of expression of the ap-
propriate gene (data not shown); the cells that did not fat granules may serve as a model for mammalian fat
storage. Considering the early state of the studies, it ishave a lowered level of the targeted gene could then
serve as controls. not yet clear whether the pathways in worms model fat
storage in adipocytes or in other mammalian cells, suchTo evaluate the potential of the stable lines to accumu-
late fat, we grew five PPAR shRNA lines and five lpd-3 as hepatocytes, that can store fat. Taken together, our
data suggest a conservation of molecules that regulateshRNA lines to confluence and induced them to become
adipocytes. After induction, two of the PPAR shRNA fat biology across a wide evolutionary distance.
One goal of developing a model system is that furthercell lines accumulated lipid, while three did not (Figure
6A). We then assessed PPAR expression and found studies might lead to a better understanding of the mo-
lecular mechanisms that control adipocyte formationthat those cell lines that contained fat had high levels
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Figure 6. lpd-3 Is Required for Mammalian Lipid Accumulation
(A) 3T3-L1 cells containing the PPAR shRNA cassette were induced to undergo adipogenesis as described (Green and Kehinde, 1975). After
10 days of induction, lipid accumulation was assessed by visual inspection. While PPAR shRNA stable lines 5 and 10 accumulated many
lipid droplets, PPAR shRNA stable lines 3, 4, and 6 did not accumulate lipid upon induction.
(B) Cells shown in (A) were harvested and processed for RT-PCR analysis. Of note, the inability to accumulate lipid correlated with an shRNA-
dependent decrease in PPAR expression.
(C) 3T3-L1 cells that contained the lpd-3 shRNA cassette were induced and evaluated for lipid accumulation. While lpd-3 shRNA stable line
1 accumulated lipid droplets, lpd-3 shRNA stable lines 4, 6, 8, and 9 did not.
(D) RT-PCR of cells shown in (C) demonstrated that the lines that did not accumulate lipid after induction were depleted in lpd-3 expression.
(E) RT-PCR analysis on the induced PPAR shRNA and lpd-3 shRNA cell lines (A and C) demonstrated that cells with low levels of either
lpd-3 or PPAR did not express either C/EBP, an adipogenic gene, or LPL and adipsin, markers of terminally differentiated fat. While the
PPAR shRNA lines lacking PPAR expressed lpd-3, the lpd-3 shRNA cells with reduced lpd-3 levels (4, 6, 8, and 9) did not express PPAR.
HPRT is a loading control. The RT samples had no reverse transcriptase included in the reaction.
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and function and may identify new therapeutic targets, diabetes treatment, is of potential concern because of
presumed pleiotropic effects. However, worms wereproviding tangible benefits to man. Analysis of lipid-
depleted mutants and identification of the responsible able to complete embryogenesis and developed to mid-
larval stages when mitochondrial function was inhibited,genes may increase our knowledge of nematode, and,
potentially, mammalian, fat storage. Our pilot screen for so it is possible that a therapeutic window may exist for
such a therapy.lipid-depleted worms identified a surprisingly diverse
array of genes representing various aspects of cellular lpd-3 encodes a novel protein that is conserved from
worms to man. Worm lpd-3 is expressed in the intestine,functions. It is notable that none of the genes we isolated
are in the biosynthetic pathway; rather, they encompass the major site of fat storage, and the putative mammalian
homolog is expressed in mouse and human fat. Theproteins of extremely diverse structures and mecha-
nisms (RNA binding proteins, MRC genes, AAA-ATP- expression analysis showed that (1) lpd-3 appears to
be present in relatively high levels in three human tis-ases, novel genes, etc.). This suggests a high complexity
to this important biological problem. Although the isola- sues—brain, testis, and fat, (2) lpd-3 is regulated during
3T3-L1 adipogenesis, and (3) lpd-3 is present at highertion of mitochondrial genes as important in energy stor-
age can potentially be rationalized on the basis of our levels in developing, rather than mature, fat. To examine
the function of lpd-3 in a mammalian system, we per-current understanding of mitochondrial function, sur-
prisingly few of the genes that we identified in the pilot formed necessity tests in the 3T3-L1 adipocyte model
with an RNAi technique termed short-hairpin RNAscreen had a preexisting link to fat biology. One of the
genes we identified—mac-1—had been shown, just as (shRNA) (Brummelkamp et al., 2002; Yu et al., 2002). We
generated stable 3T3-L1 lines containing shRNA di-we found, to have a larval arrest phenotype, but the
preliminary studies did not include any analysis of fat rected against either PPAR or mlpd-3 and found that
greater than 50% of the lines had markedly reduced(Wu et al., 1999). On the basis of our pilot screen, we
estimate that approximately 5%–10% of larval arrest/ levels of the targeted gene, which correlates with other
reported shRNA results (Brummelkamp et al., 2002). Oflethal worms will display the lpd phenotype; if this is so,
then we should be able to identify approximately 25–75 note, shRNA lines that were deficient in either PPAR
or mlpd-3 lacked lipid accumulation. However, we foundlpd genes. This suggests that a full-scale C. elegans lpd
screen will identify many new genes that regulate fat that a small minority of shRNA clones directed against
either gene did not completely behave as predicted,biology.
One key feature of a model system is its ability to which may be expected from a new technique. Nonethe-
less, the trends were clear: PPAR and mlpd-3 are re-uncover genes that are important in the analogous pro-
cess in humans. The finding that seven of the eight quired in 3T3-L1 cells for lipid accumulation. Molecular
analysis of the shRNA clones revealed a potentially ex-genes we identified in the pilot screen had clear mamma-
lian homologs suggests that the worm model is robust citing insight; we found that cells lacking the normal
amount of PPAR maintained lpd-3 expression, whileand increases the likelihood that we will be able to make
connections to mammalian fat biology. In that regard, cells with reduced lpd-3 levels were deficient in PPAR
expression. The cells expressing lpd-3 shRNA alsowe attempted to extend the data from worms to mam-
mals with three of the newly identified lpd genes. Sur- lacked C/EBP expression. These data suggest that
lpd-3 acts upstream of PPAR. Since C/EBP is thoughtprisingly, all three that we tested were required in mam-
to act upstream of PPAR and is at the top of the tran-malian fat accumulation, just as in worms. This strongly
scriptional cascade (Rosen et al., 2002), its absence insuggests that other genes identified in worm fat screens
mlpd-3 deficient cells is consistent with the notion thatwill play a role in mammalian fat biology. The three lpd
mlpd-3 functions quite proximally in the pathway. How-genes that we selected to examine in the mammalian
ever, mammalian adipogenesis involves a series of posi-system represent two ends of the spectrum of genes
tive- and negative-feedback loops (Rosen et al., 2000),that we anticipate finding in the C. elegans screens. The
so it is formally possible that mlpd-3 acts later than theMRC genes represent known and characterized genes
data might indicate.that have in some way been suggested to have roles
The control of fat storage is a fundamental problemin energy storage, while lpd-3 was unknown, had no
that has important public health ramifications. The datadiscernable functional domains, and had no known
provided here support the notion that C. elegans mayfunction.
indeed be a useful genetic model system to identifyCOX Vb (lpd-4), one of the MRC genes that we identi-
and study new genes involved in mammalian adipocytefied, is a component of MRC complex IV. Recent data
differentiation and fat storage. Although we have electedimplicate reduced complex IV activity as pathogenic for
to study a specific and directed worm fat phenotype,two types of human fat abnormalities: HAART-related
the lpd larval phenotype, C. elegans can also be furtherlipodystrophy and multiple symmetrical lipomatosis
exploited to understand other aspects of fat biology.(Brinkman et al., 1999; Zaera et al., 2001). Of note, MRC
For example, one could screen to identify worms withgenes are regulated in a PPAR-dependent fashion
too much fat or for other adult fat phenotypes. Through(Mueller et al., 2002). We found that blocking MRC func-
these approaches, the molecular basis that underliestion, with two distinct chemical inhibitors, decreased fat
this important biological area can be better elucidated.accumulation in worms and in a mammalian adipogenic
cell line. This demonstrates the key role that the mito-
Experimental Procedureschondria play in worm and mammalian fat accumulation.
One goal of studying fat biology in worms is to identify
Sudan Black and Nile Red Staining
proteins that might be therapeutic targets for obesity, For Sudan black staining, well-fed and starved (removed from food
diabetes, or other metabolic diseases. Inhibiting mito- for 8 hr) worms were washed in M9 and fixed in 1% paraformalde-
hyde in M9. The worms were then subjected to three freeze-thawchondrial function in humans, for weight loss or as a
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cycles and dehydrated through an ethanol series. The worms were of Dimes. J.M.G. is an American Cancer Society Scholar and a
Leukemia & Lymphoma Society Scholar.stained overnight in a 50% saturated solution of Sudan black in
70% ethanol, rehydrated, and photographed. For Nile red staining,
worms were grown on plates with 1 ng/ml Nile red and photographed Received: June 5, 2002
with epifluorescence (rhodamine channel). Revised: November 20, 2002
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